Scarcell Therapeutics
Game Changing Allogeneic Cell Therapy for Tissue Repair2 major innovations in allogeneic cell therapy
![Chrome](/img/image_1_homepage.png)
Impacts
Technological impact
• Innovative bioproduction using non-modified human GFs decreases production costs to allow greater patient access to effective allogeneic cell therapy
Clinical impact
•A unique combination of anti-inflammatory and tissue repair properties via immune tolerance may allow for new treatments to be created for many diseases, such as inflammatory and tissue repair disorders.
Social impact
• Scarcell Therapeutics' goal is to provide an effective new regenerative therapy at a lower cost
Environmental impact
• Environmentally friendly bioproduction process
• May reduce drug consumption
Scarcell therapeutics collaborates with a network of renowned partners and institutional bodies
The production process is developed in partnership with CDMOs![Clients](/img/partners/EFS.png)
![Clients](/img/partners/bio_elpida.jpg)
![Clients](/img/partners/france_biotech.png)
![Clients](/img/partners/medicen.png)
![Clients](/img/partners/leem.png)
![Clients](/img/partners/bpi.png)
![Clients](/img/partners/france2030.jpg)
![Clients](/img/partners/1.png)
![Clients](/img/partners/2.png)
![Clients](/img/partners/3.png)